ILK and lung adenocarcinoma: In lung adenocarcinoma, as reported, ILK can regulate KRAS, IPP complex and Ras suppressor-1 (RSU1) to promote cancer cell multiplication, migration and epithelial-mesenchymal transition (EMT), and its high expression is pertinent to poor prognosis [21].